28 May 2014
Bob Olsson, PhD, Wins 2014 Alzheimer Award
The Journal of Alzheimer's Disease is are proud to announce that Bob Olsson, PhD, has been chosen as the recipient of the 2014 Alzheimer Award presented by the Journal of Alzheimer’s Disease in recognition of his outstanding work on microglia markers and Alzheimer’s disease.
21 May 2014
Compound Reverses Symptoms of Alzheimer's Disease in Mice, SLU Research Shows
St. Louis -- A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer’s disease, according to findings in the May issue of the Journal of Alzheimer’s Disease.
8 April 2014
Testosterone therapy can damage brain health in Caucasian men
Forth Worth, Texas - Ads touting testosterone replacement therapy are ubiquitous on radio and television. But medical research has determined that its success at enhancing libido may come at a price.
7 April 2014
No Evidence of AD-Associated Changes in Adolescents Carrying Genetic Risk Factors
Two studies published in the Journal of Alzheimer’s Disease indicate that some of the pathologic changes associated with Alzheimer’s disease in older individuals are not apparent in young people who carry the apolipoprotein (APOE) genetic risk factor for developing the disease.
3 April 2014
JAD Introduces New Section: Ethics Review
JAD has launched a new feature, “Ethics Review,” which will provide support and guidance to move ethical decision-making forward. The goal is to create a forum for dementia researchers, clinicians and policy makers to bring greater clarity and constructive discussion to define risks and benefits from the perspectives of diverse disciplines.
16 March 2014
New Therapeutic Target Discovered for Alzheimer's Disease
A team from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer’s disease.
18 February 2014
SDSC/UC San Diego Researchers Hone in on Alzheimer's Disease
Researchers studying peptides using the Gordon supercomputer at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego (UCSD) have found new ways to elucidate the creation of the toxic oligomers associated with Alzheimer’s disease.
18 February 2014
Neuropsychological assessment more efficient than MRI for tracking disease progression in memory clinic patients
Amsterdam, NL – Investigators at the University of Amsterdam, The Netherlands, have shown that progression of disease in memory clinic patients can be tracked efficiently with 45 minutes of neuropsychological testing.
7 February 2014
JAD announces sister-journal: Journal of Neuromuscular Diseases
After the successful launch of sister publications the Journal of Parkinson’s Disease and the Journal of Huntington’s Disease, JAD is delighted to announce the forthcoming launch of the Journal of Neuromuscular Diseases (JND).
Pages
